Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
MARKETS
SECTOR : PHARMA & BIOTECH
INDUSTRY : MAJOR PHARMACEUTICALS
REGENERON PHARMACEUTICALS, INC.
Regeneron Pharmaceuticals, Inc.
XNAS: REGN
Turnaround Potential
Download real time
777.50
-19.05
(
-2.39
%)
New 52W High in past week
350.1K
XNAS Volume
XNAS
12 Jan, 2026 12:31 PM (EST)
Watchlist
Portfolio
Alert
My Notes
Board Meeting
The board meeting for Regeneron Pharma is scheduled for today, for the purpose of 44th Annual J.P. Morgan Healthcare Conference PR Newswire
See details
Overview
Buy Sell Zone
Financials
Technicals
Price History/Seasonality
Ownership
Politician Trades
Insider Deals
Corporate Actions
All
Dividend
Split
Board Meetings
About
Regeneron Pharma - REGN - stock price prediction, stock price target, analyst ratings from 26 analysts
Regeneron Pharma has a share price target of US$ 825 and profit growth estimate of -2.4% for FY25, based on top 26 analyst calls.
Forecaster Screeners